As a poly (ADP-Ribose) polymerase (PARP) inhibitor, NU-1025, can regulate Tp53 in human glioblastoma cells, thereby affecting the sensitivity of tumor cells to radiotherapy 39. This evidence concerns the gene TP53 and glioblastoma.